Maternal thyroid disease and preterm birth: Systematic review and meta-analysis

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 11, 2015, Pages 4325-4331

  Sheehan, Penelope M ^a,b   Nankervis, Alison ^b   Araujo, Edward ^c   Da Silva Costa, Fabricio ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL WOMEN'S HOSPITAL   (Australia)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CASE CONTROL STUDY; COHORT ANALYSIS; FEMALE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; META ANALYSIS; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PREGNANCY OUTCOME; THYROID DISEASES;

ADULT; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PREGNANCY OUTCOME; THYROID DISEASES;

EID: 84958635203     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2015-3074     Document Type: Review

References (35)

1. Chang HH, Larson J, Blencowe H, et al; Born Too Soon preterm prevention analysis group. Preventing preterm births: analysis of trends and potential reductions with interventions in 39 countries with very high human development index. Lancet. 2013;381:223-234.
2. Romero R, Dey SK, Fisher SJ. Preterm labor: one syndrome, many causes. Science. 2014;345:760-765.
3. Nathan N, Sullivan SD. Thyroid disorders during pregnancy. Endocrinol Metab Clin North Am. 2014;43:573-597.
4. AnderssonM,Karumbunathan V, ZimmermannMB.Global iodine status in 2011 and trends over the past decade. J Nutrition. 2012; 142:744-750.
5. Stagnaro-Green A. Maternal thyroid disease and preterm delivery. J Clin Endocrinol Metab. 2009;94:21-25.
6. Wells G, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in metaanalyses. Proc 3rd Symposium on Systematic Reviews, Oxford, UK, 2000.
7. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22: 719-748.
8. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-560.
9. Cochran WG. The combination of estimates from different experiments. Biometrics. 1954;10:101-129.
10. Werder E, Mendola P, Männistö T, O'Loughlin J, Laughon SK. Effect of maternal chronic disease on obstetric complications in twin pregnancies in a United States cohort. Fertil Steril. 2013;100:142-149.
11. Reid SM, Middleton P, Cossich MC, Crowther CA, Bain E. Interventions for clinical and subclinical hypothyroidism pre-pregnancy and during pregnancy. Cochrane Database Syst Rev. 2013;(5): CD007752.
12. Velkeniers B, Van Meerhaeghe A, Poppe K, Unuane D, Tournaye H, Haentjens P. Levothyroxine treatment and pregnancy outcome in women with subclinical hypothyroidism undergoing assisted reproduction technologies: systematic review and meta-analysis of RCTs. Hum Reprod Update. 2013;19:251-258.
13. Torremante P, Flock F, Kirschner W. Free thyroxine level in the high normal reference range prescribed for nonpregnant women may reduce the preterm delivery rate in multiparous. J Thyroid Res. 2011;2011:905734.
14. Reid SM, Middleton P, Cossich MC, Crowther CA. Interventions for clinical and subclinical hypothyroidism in pregnancy. Cochrane Database Syst Rev. 2010;(7):CD007752.
15. Ajmani SN, Aggarwal D, Bhatia P, Sharma M, Sarabhai V, Paul M. Prevalence of overt and subclinical thyroid dysfunction among pregnant women and its effect on maternal and fetal outcome. J Obstet Gynaecol India. 2014;64:105-110.
16. Karakosta P, Alegakis D, Georgiou V, et al. Thyroid dysfunction and autoantibodies in early pregnancy are associated with increased risk of gestational diabetes and adverse birth outcomes. J Clin Endocrinol Metab. 2012;97:4464-4472.
17. Ashoor G, Maiz N, Rotas M, Jawdat F, Nicolaides KH. Maternal thyroid function at 11-13 weeks of gestation and spontaneous preterm delivery. Obstet Gynecol. 2011;117:293-298.
18. Tierney K, Delpachitra P, GrossmannM,et al. Thyroid function and autoantibody status among women who spontaneously deliver under 35 weeks of gestation. Clin Endocrinol (Oxf). 2009;71:892-895.
19. Khan I, Witczak JK, Hadjieconomou S, Okosieme OE. Preconception thyroid-stimulating hormone and pregnancy outcomes in women with hypothyroidism. Endocr Pract. 2013;19:656-662.
20. Matalon S, Sheiner E, Levy A, Mazor M, Wiznitzer A. Relationship of treated maternal hypothyroidism and perinatal outcome. J Reprod Med. 2006;51:59-63.
21. Allan WC, Haddow JE, Palomaki GE, et al. Maternal thyroid deficiency and pregnancy complications: implications for population screening. J Med Screen. 2000;7:127-130.
22. Antolic B, Gersak K, Verdenik I, Novak-Antolic Z. Adverse effects of thyroid dysfunction on pregnancy and pregnancy outcome: epidemiologic study in Slovenia. J Matern Fetal Neonatal Med. 2006; 19:651-654.
23. Ong GS, Hadlow NC, Brown SJ, Lim EM, Walsh JP. Does the thyroid-stimulating hormone measured concurrently with first trimester biochemical screening tests predict adverse pregnancy outcomes occurring after 20 weeks gestation? J Clin Endocrinol Metab. 2014;99:E2668-E2672.
24. Williams F, Watson J, Ogston S, Hume R, Willatts P, Visser T; Scottish Preterm Thyroid Group. Mild maternal thyroid dysfunction at delivery of infants born-34 weeks and neurodevelopmental outcome at 5.5 years. J Clin Endocrinol Metab 2012;97:1977-1985.
25. Stagnaro-Green A, Chen X, Bogden JD, Davies TF, Scholl TO. The thyroid and pregnancy: a novel risk factor for very preterm delivery. Thyroid. 2005;15:351-357.
26. Cleary-Goldman J, Malone FD, Lambert-Messerlian G, et al. Maternal thyroid hypofunction and pregnancy outcome. Obstet Gynecol. 2008;112:85-92.
27. Su PY, Huang K, Hao JH, Xu YQ, Yan SQ, Li T, Xu YH, Tao FB. Maternal thyroid function in the first twenty weeks of pregnancy and subsequent fetal and infant development: a prospective population-based cohort study in China. J Clin Endocrinol Metab. 2011; 96:3234-3241.
28. León G, Murcia M, Rebagliato M, et al. Maternal thyroid dysfunction during gestation, preterm delivery, and birthweight. The Infancia y Medio Ambiente Cohort, Spain. Paediatr Perinat Epidemiol. 2015;29:113-122.
29. Korevaar TI, Schalekamp-Timmermans S, de Rijke YB, et al. Hypothyroxinemia and TPO-antibody positivity are risk factors for premature delivery: the generation R study. J Clin Endocrinol Metab. 2013;98:4382-4390.
30. van den Boogaard E, Vissenberg R, Land JA, et al. Significance of (sub)clinical thyroid dysfunction and thyroid autoimmunity before conception and in early pregnancy: a systematic review. Hum Reprod Update. 2011;17:605-619.
31. Andersen SL, Olsen J, Wu CS, Laurberg P. Low birth weight in children born to mothers with hyperthyroidism and high birth weight in hypothyroidism, whereas preterm birth iscommonin both conditions: a Danish National Hospital Register Study. Eur Thyroid J. 2013;2:135-144.
32. Wikner BN, Sparre LS, Stiller CO, Källén B, Asker C. Maternal use of thyroid hormones in pregnancy and neonatal outcome. Acta Obstet Gynecol Scand. 2008;87:617-627.
33. He X, Wang P, Wang Z, He X, Xu D, Wang B. Thyroid antibodies and risk of preterm delivery: a meta-analysis of prospective cohort studies. Eur J Endocrinol. 2012;167:455-464.
34. Hulchiy M, Zhang H, Cline JM, Hirschberg AL, Sahlin L. Receptors for thyrotropin-releasing hormone, thyroid-stimulating hormone, and thyroid hormones in the macaque uterus: effects of long-term sex hormone treatment. Menopause. 2012;19:1253-1259.
35. Ticconi C, Zicari A, Belmonte A, Realacci M, Rao ChV, Piccione E. Pregnancy-promoting actions of HCG in human myometrium and fetal membranes. Placenta 2007;28(Suppl A):S137-S143.